Beneficial effects of levobupivacaine regional anaesthesia on postoperative opioid induced hyperalgesia in diabetic mice

Journal of Translational Medicine

Volumn 13, Issue 1, 2015, Pages

  Gomez Brouchet, Anne ^a   Blaes, Nelly ^d   Mouledous, Lionel ^c   Fourcade, Olivier ^b   Tack, Ivan ^d   Francès, Bernard ^e   Girolami, Jean Pierre ^d   Minville, Vincent ^b,d  

^a Service d'anatomie cytologie pathologique   (France)

^b TOULOUSE UNIVERSITY HOSPITAL   (France)

^c INSTITUT DE PHARMACOLOGIE ET DE BIOLOGIE STRUCTURALE   (France)

^d Université de Toulouse   (France)

^e Université Paul Sabatier   (France)

Author keywords

Diabetes; Levobupivacaine; Naloxone; Opioid induced hyperalgesia; Pain; Plantar incision; Regional anaesthesia; Sufentanil

Indexed keywords

LEVOBUPIVACAINE; OPIATE; SUFENTANIL; BUPIVACAINE; NARCOTIC ANALGESIC AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; HYPERALGESIA; INSULIN DEPENDENT DIABETES MELLITUS; MALE; MECHANICAL NOCICEPTION; MOUSE; NOCICEPTION; NONHUMAN; OBSERVATIONAL STUDY; OPIOID INDUCED HYPERALGESIA; PAIN ASSESSMENT; PLANTAR INCISION; POSTOPERATIVE PERIOD; REGIONAL ANESTHESIA; SURGICAL TECHNIQUE; THERMAL NOCICEPTION; ANALOGS AND DERIVATIVES; ANIMAL; C57BL MOUSE; CHEMICALLY INDUCED; COMPLICATION; DRUG EFFECTS; EXPERIMENTAL DIABETES MELLITUS; INFLAMMATION; NERVE BLOCK; PATHOLOGY; POSTOPERATIVE COMPLICATIONS; SCIATIC NERVE; SKIN; WOUND HEALING;

ANALGESICS, OPIOID; ANESTHESIA, CONDUCTION; ANIMALS; BUPIVACAINE; DIABETES MELLITUS, EXPERIMENTAL; HYPERALGESIA; INFLAMMATION; MALE; MICE, INBRED C57BL; NERVE BLOCK; POSTOPERATIVE COMPLICATIONS; SCIATIC NERVE; SKIN; WOUND HEALING;

EID: 84934298570     PISSN: None     EISSN: 14795876     Source Type: Journal    
DOI: 10.1186/s12967-015-0575-0     Document Type: Article

References (56)

1. Wild S, Roglic G, Green A, Sicree R, King H (2004) Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 27:1047-1053
2. Brem H, Tomic-Canic M, Entero H, Hanflik AM, Wang VM, Fallon JT et al (2007) The synergism of age and db/db genotype impairs wound healing. Exp Gerontol 42:523-531
3. Shaw JE, Sicree RA, Zimmet PZ (2010) Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract 87:4-14
4. Feldman EL, Russell JW, Sullivan KA, Golovoy D (1999) New insights into the pathogenesis of diabetic neuropathy. Curr Opin Neurol 12:553-563
5. Dyck PJ, Dyck PJ, Larson TS, O'Brien PC, Velosa JA (2000) Patterns of quantitative sensation testing of hypoesthesia and hyperalgesia are predictive of diabetic polyneuropathy: a study of three cohorts. Nerve growth factor study group. Diabetes Care 23:510-517
6. Hoffman DL, Sadosky A, Dukes EM, Alvir J (2010) How do changes in pain severity levels correspond to changes in health status and function in patients with painful diabetic peripheral neuropathy? Pain 149:194-201
7. Williams BA, Murinson BB (2008) Diabetes mellitus and subclinical neuropathy: a call for new paths in peripheral nerve block research. Anesthesiology 109:361-362
8. Joly V, Richebé P, Guignard B, Fletcher D, Maurette P, Sessler DI et al (2005) Remifentanil-induced postoperative hyperalgesia and its prevention with small-dose ketamine. Anesthesiology 103:147-155
9. Eisenach JC, Tong C, Curry RS (2015) Failure of intrathecal ketorolac to reduce remifentanil-induced postinfusion hyperalgesia in humans. Pain 156:81-87
10. Annila P, Rorarius M, Koivu H, Aura S, Lähde Y (2007) Anaesthesia with remifentanil infusion in diabetic versus non-diabetic patients undergoing vitrectomy. A Holter-controlled study. Acta Anaesthesiol Belg 58:33-35
11. Kim HS, Kim SY, Kwak YL, Hwang KC, Shim YH (2012) Hyperglycemia attenuates myocardial preconditioning of remifentanil. J Surg Res 174:231-237
12. Lirk P, Rutten MVH, Haller I, Stevens MF, Laudolff-Birmingham J, Hollmann M et al (2013) Management of the patient with diabetic peripheral neuropathy presenting for peripheral regional anesthesia: a European survey and review of literature. Minerva Anestesiol 79:1039-1048
13. Calcutt NA, Jorge MC, Yaksh TL, Chaplan SR (1996) Tactile allodynia and formalin hyperalgesia in streptozotocin-diabetic rats: effects of insulin, aldose reductase inhibition and lidocaine. Pain 68:293-299
14. Lee-Kubli CA, Mixcoatl-Zecuatl T, Jolivalt CG, Calcutt NA (2014) Animal models of diabetes-induced neuropathic pain. Curr Top Behav Neurosci 20:147-170
15. Kalichman MW, Calcutt NA (1992) Local anesthetic-induced conduction block and nerve fiber injury in streptozotocin-diabetic rats. Anesthesiology 77:941-947
16. Combettes E, Benhamou D, Mazoit J-X, Beloeil H (2010) Comparison of a bupivacaine peripheral nerve block and systemic ketoprofen on peripheral inflammation and hyperalgesia in rats. Eur J Anaesthesiol 27:642-647
17. Fletcher D, Martinez V (2014) Opioid-induced hyperalgesia in patients after surgery: a systematic review and a meta-analysis. Br J Anaesth 112:991-1004
18. Martinez V, Fletcher D (2012) Prevention of opioid-induced hyperalgesia in surgical patients: does it really matter? Br J Anaesth 109:302-304
19. Cabañero D, Campillo A, Célérier E, Romero A, Puig MM (2009) Pronociceptive effects of remifentanil in a mouse model of postsurgical pain: effect of a second surgery. Anesthesiology 111:1334-1345
20. Blaes N, Pécher C, Mehrenberger M, Cellier E, Praddaude F, Chevalier J et al (2012) Bradykinin inhibits high glucose- and growth factor-induced collagen synthesis in mesangial cells through the B2-kinin receptor. Am J Physiol Ren Physiol 303:F293-303
21. Banik RK, Woo YC, Park SS, Brennan TJ (2006) Strain and sex influence on pain sensitivity after plantar incision in the mouse. Anesthesiology 105:1246-1253
22. Xu J, Brennan TJ (2009) Comparison of skin incision vs. skin plus deep tissue incision on ongoing pain and spontaneous activity in dorsal horn neurons. Pain 144:329-339
23. Sokolsky-Papkov M, Golovanevski L, Domb AJ, Weiniger CF (2009) Prolonged local anesthetic action through slow release from poly (lactic acid co castor oil). Pharm Res 26:32-39
24. Minville V, Fourcade O, Girolami JP, Tack I (2010) Opioid-induced hyperalgesia in a mice model of orthopaedic pain: preventive effect of ketamine. Br J Anaesth 104:231-238
25. Li X, Angst MS, Clark JD (2001) A murine model of opioid-induced hyperalgesia. Brain Res Mol Brain Res 86:56-62
26. Grastilleur S, Mouledous L, Bedel J, Etcheverry J, Bader M, Girolami JP et al (2013) Role of kinin B2 receptors in opioid-induced hyperalgesia in inflammatory pain in mice. Biol Chem 394:361-368
27. Minville V, Laffosse J-M, Fourcade O, Girolami JP, Tack I (2008) Mouse model of fracture pain. Anesthesiology 108:467-472
28. Minville V, Fourcade O, Mazoit JX, Girolami JP, Tack I (2011) Ondansetron does not block paracetamol-induced analgesia in a mouse model of fracture pain. Br J Anaesth 106:112-118
29. Menéndez L, Lastra A, Hidalgo A, Baamonde A (2002) Unilateral hot plate test: a simple and sensitive method for detecting central and peripheral hyperalgesia in mice. J Neurosci Methods 113:91-97
30. Banik RK, Brennan TJ (2009) Trpv1 mediates spontaneous firing and heat sensitization of cutaneous primary afferents after plantar incision. Pain 141:41-51
31. Bujalska M, Makulska-Nowak H (2009) Bradykinin receptors antagonists and nitric oxide synthase inhibitors in vincristine and streptozotocin induced hyperalgesia in chemotherapy and diabetic neuropathy rat model. Neuro Endocrinol Lett 30:144-152
32. Bierhaus A, Nawroth PP (2012) Critical evaluation of mouse models used to study pain and loss of pain perception in diabetic neuropathy. Exp Clin Endocrinol Diabetes 120:188-190
33. Sullivan KA, Lentz SI, Roberts JL, Feldman EL (2008) Criteria for creating and assessing mouse models of diabetic neuropathy. Curr Drug Targets 9:3-13
34. Aley KO, Levine JD (2002) Different peripheral mechanisms mediate enhanced nociception in metabolic/toxic and traumatic painful peripheral neuropathies in the rat. Neuroscience 111:389-397
35. Ohsawa M, Hayashi S-S, Kamei J (2010) Effect of acute topical application of +-pentazocine on the mechanical allodynia in diabetic mice. Eur J Pharmacol 641:49-53
36. Zhang YP, Eber A, Yuan Y, Yang Z, Rodriguez Y, Levitt RC et al (2013) Prophylactic and antinociceptive effects of coenzyme Q10 on diabetic neuropathic pain in a mouse model of type 1 diabetes. Anesthesiology 118:945-954
37. Kroin JS, Buvanendran A, Tuman KJ, Kerns JM (2012) Effect of acute versus continuous glycemic control on duration of local anesthetic sciatic nerve block in diabetic rats. Reg Anesth Pain Med 37:595-600
38. Kroin JS, Buvanendran A, Williams DK, Wagenaar B, Moric M, Tuman KJ et al (2010) Local anesthetic sciatic nerve block and nerve fiber damage in diabetic rats. Reg Anesth Pain Med 35:343-350
39. Méleine M, Rivat C, Laboureyras E, Cahana A, Richebé P (2012) Sciatic nerve block fails in preventing the development of late stress-induced hyperalgesia when high-dose fentanyl is administered perioperatively in rats. Reg Anesth Pain Med 37:448-454
40. Rivat C, Bollag L, Richebé P (2013) Mechanisms of regional anaesthesia protection against hyperalgesia and pain chronicization. Curr Opin Anaesthesiol 26(5)621-625
41. Ahmadi S, Golbaghi H, Azizbeigi R, Esmailzadeh N (2014) N-methyl-d-aspartate receptors involved in morphine-induced hyperalgesia in sensitized mice. Eur J Pharmacol 737:85-90
42. Chen S-R, Samoriski G, Pan H-L (2009) Antinociceptive effects of chronic administration of uncompetitive NMDA receptor antagonists in a rat model of diabetic neuropathic pain. Neuropharmacology 57:121-126
43. Niesters M, Dahan A (2012) Pharmacokinetic and pharmacodynamic considerations for NMDA receptor antagonists in the treatment of chronic neuropathic pain. Exp Opin Drug Metab Toxicol 8:1409-1417
44. Daulhac L, Maffre V, Mallet C, Etienne M, Privat A-M, Kowalski-Chauvel A et al (2011) Phosphorylation of spinal N-methyl-d-aspartate receptor NR1 subunits by extracellular signal-regulated kinase in dorsal horn neurons and microglia contributes to diabetes-induced painful neuropathy. Eur J Pain 15:169e1-169.e12
45. Maiese K, Chong ZZ, Shang YC, Wang S (2013) Novel directions for diabetes mellitus drug discovery. Exp Opin Drug Discov 8:35-48
46. Obara I, Tochiki KK, Géranton SM, Carr FB, Lumb BM, Liu Q et al (2011) Systemic inhibition of the mammalian target of rapamycin (mTOR) pathway reduces neuropathic pain in mice. Pain 152:2582-2595
47. Xu J-T, Zhao J-Y, Zhao X, Ligons D, Tiwari V, Atianjoh FE et al (2014) Opioid receptor-triggered spinal mTORC1 activation contributes to morphine tolerance and hyperalgesia. J Clin Invest 124:592-603
48. Mert T, Oksuz H, Tugtag B, Kilinc M, Senoglu N, Bilgin R (2014) Modulating actions of NMDA receptors on pronociceptive effects of locally injected remifentanil in diabetic rats. Pharmacol Rep 66:1065-1072
49. Hahnenkamp K, Durieux ME, Hahnenkamp A, Schauerte SK, Hoenemann CW, Vegh V et al (2006) Local anaesthetics inhibit signalling of human NMDA receptors recombinantly expressed in Xenopus laevis oocytes: role of protein kinase C. Br J Anaesth 96:77-87
50. Furutani K, Ikoma M, Ishii H, Baba H, Kohno T (2010) Bupivacaine inhibits glutamatergic transmission in spinal dorsal horn neurons. Anesthesiology 112:138-143
51. Paganelli MA, Popescu GK (2015) Actions of bupivacaine, a widely used local anesthetic, on NMDA receptor responses. J Neurosci 35:831-842
52. Zeren S, Kesici S, Kesici U, Isbilir S, Turkmen UA, Ulusoy H et al (2013) Effects of levobupivacaine on wound healing. Anesth Analg 116:495-499
53. Waite A, Gilliver SC, Masterson GR, Hardman MJ, Ashcroft GS (2010) Clinically relevant doses of lidocaine and bupivacaine do not impair cutaneous wound healing in mice. Br J Anaesth 104:768-773
54. Dere K, Sen H, Teksoz E, Ozkan S, Dagli G, Sucullu I et al (2009) The comparison of the effects of different doses of levobupivacaine infiltration on wound healing. J Invest Surg 22:112-116
55. Kocum A, Turkoz A, Bozdogan N, Caliskan E, Eker EH, Arslan G (2010) Femoral and sciatic nerve block with 0.25% bupivacaine for surgical management of diabetic foot syndrome: an anesthetic technique for high-risk patients with diabetic nephropathy. J Clin Anesth 22:363-366
56. Cuvillon P, Reubrecht V, Zoric L, Lemoine L, Belin M, Ducombs O et al (2013) Comparison of subgluteal sciatic nerve block duration in type 2 diabetic and non-diabetic patients. Br J Anaesth 110:823-830